ARENA PHARMACEUTICALS$5.96
-0.08
| Last Trade: |
5.96 |
| Trade Time: |
May 25 11:09 AM Eastern Daylight Time |
| Change: |
-0.08 (-1.31 %) |
| Prev Close: |
6.04 |
| Open: |
5.99 |
| Bid: |
5.96 |
| Ask: |
5.97 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
3/29/2012
|
Bielasz Jennifer Kathleen
|
Sr.Dir. of Acct. & Cont. (PAO)
|
6,250
|
$1.49
|
66.84%
|
|
3/29/2012
|
Bielasz Jennifer Kathleen
|
Sr.Dir. of Acct. & Cont. (PAO)
|
-6,250
|
$3.04
|
-40.06%
|
|
3/29/2012
|
Bielasz Jennifer Kathleen
|
Sr.Dir. of Acct. & Cont. (PAO)
|
-4,550
|
$3.01
|
-48.66%
|
|
1/6/2012
|
HOFFMAN ROBERT
|
VP, Finance and CFO
|
150
|
$1.64
|
1.24%
|
|
1/6/2012
|
HOFFMAN ROBERT
|
VP, Finance and CFO
|
-150
|
$1.63
|
-1.22%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ARNA), click here.
-
If you're looking for cutting-edge companies that have a chance to triple or quadruple in the coming months and years, don't look any further than today's best small biotechs, writes Mike Murphy of ...
Read More »
-
Nutrisystem's membership weakness is a worrisome sign.
Read More »
-
Medifast gets a lot of doubt on the Street.
Read More »
Free Reports
|
|
